KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Research & Development: 2011-2024

Historic Research & Development for Precigen (PGEN) over the last 14 years, with Dec 2024 value amounting to $53.1 million.

  • Precigen's Research & Development rose 8.86% to $12.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.1 million, marking a year-over-year decrease of 15.11%. This contributed to the annual value of $53.1 million for FY2024, which is 9.17% up from last year.
  • Precigen's Research & Development amounted to $53.1 million in FY2024, which was up 9.17% from $48.6 million recorded in FY2023.
  • Precigen's 5-year Research & Development high stood at $53.1 million for FY2024, and its period low was $39.4 million during FY2020.
  • Over the past 3 years, Precigen's median Research & Development value was $48.6 million (recorded in 2023), while the average stood at $49.6 million.
  • In the last 5 years, Precigen's Research & Development plummeted by 40.86% in 2020 and then rose by 21.57% in 2021.
  • Yearly analysis of 5 years shows Precigen's Research & Development stood at $39.4 million in 2020, then rose by 21.57% to $47.9 million in 2021, then declined by 1.59% to $47.2 million in 2022, then increased by 3.06% to $48.6 million in 2023, then increased by 9.17% to $53.1 million in 2024.